Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
ACADIA Pharmaceuticals Inc. (ACAD) had Return on Tangible Equity of 8.91% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$278.63M |
|
$71.78M |
|
$21.65M |
|
$256.99M |
|
$242.88M |
|
$35.76M |
|
$8.84M |
|
$44.59M |
|
$44.59M |
|
$71.78M |
|
$71.78M |
|
$71.78M |
|
$71.78M |
|
$35.76M |
|
$37.60M |
|
168.84M |
|
170.65M |
|
$0.43 |
|
$0.42 |
|
| Balance Sheet Financials | |
$1.08B |
|
$3.71M |
|
$254.35M |
|
$1.33B |
|
$356.58M |
|
-- |
|
$56.91M |
|
$413.50M |
|
$917.27M |
|
$805.66M |
|
$917.27M |
|
169.15M |
|
| Cash Flow Statement Financials | |
$158.57M |
|
$-246.69M |
|
$27.22M |
|
$328.36M |
|
$267.47M |
|
$-60.89M |
|
$38.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
92.23% |
|
12.83% |
|
12.83% |
|
-- |
|
16.00% |
|
25.76% |
|
$157.88M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.74 |
|
2.00 |
|
45.04 |
|
7.83% |
|
|
Return on Tangible Equity |
8.91% |
5.39% |
|
7.83% |
|
$5.42 |
|
$0.93 |
|
$0.93 |
|